Posts with tag: SEO
The pharmaceutical industry and pharmacy benefit managers (PBMs) are clashing in Washington, D.C., as the Trump administration takes shape. Drug companies are pushing to share negotiated savings with patients and hold PBMs accountable for limiting patient choices. PBMs, like CVS Caremark, defend their value in the healthcare system, but face scrutiny over their rebate strategy and whether it leads to higher out-of-pocket costs for patients. New models, such as Walmart's $4 generics, GoodRx coupons, and Cost Plus Drugs, offer low-cost prescription access, challenging the role of PBMs.
Published on: February 20, 2025, 04:01 AM UTC
Herbalife appoints new CEO, Stephan Gratziani, as the company continues to revamp after past controversies
Published on: February 20, 2025, 03:02 AM UTC
Federal Reserve Vice Chair Philip Jefferson said a strong economy gives policymakers room to assess data before considering more rate cuts.
Published on: February 20, 2025, 12:04 AM UTC
Palantir shares plunged 10% in late trading after a Washington Post report said the US Pentagon must plan for 8% annual budget cuts, which would slash the company's government revenue.
Published on: February 20, 2025, 12:01 AM UTC
CF Industries Holdings Inc. outperforms Q4 earnings expectations with revenue of $1.52 billion, boosted by strong fertilizer demand.
Published on: February 19, 2025, 11:10 PM UTC
Coeur Mining, Inc. reports a rise in fourth-quarter net income, as well as annual revenues and earnings per share, leading to a surge in stock prices.
Published on: February 19, 2025, 11:07 PM UTC
Carvana reports Q4 revenue and profit beat, hits record annual revenue and profitability, expects continued growth in 2025.
Published on: February 19, 2025, 10:08 PM UTC
OPENLANE reports Q4 profit of $52.3 million, matching Wall Street expectations. Revenue was $455 million, surpassing forecasts, and full-year earnings are expected to be between 90 cents and $1 per share.
Published on: February 19, 2025, 10:06 PM UTC
Northern Oil and Gas reports quarterly earnings of $71.7 million, missing analyst estimates by $0.02 EPS. Revenue of $515 million also falls short of expectations, coming in at $545.5 million adjusted.
Published on: February 19, 2025, 10:06 PM UTC
Herbalife (NYSE:HLF) beats Q4 revenue estimates, driven by strong EPS and EBITDA performance. Despite weaker guidance for the next quarter, the stock jumps 13.7%. Analyze key metrics, growth trends, and investment potential with our comprehensive research report.
Published on: February 19, 2025, 10:04 PM UTC